StockWatch
·

MARATHON NEXTGEN REALTY LTD.

BSE: 503101

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
86.68
+30.2%-18.0%
Expenditure
25.39
+6.3%-30.0%
Net Profit
47.79
+30.5%-21.0%
OPM %
59.62%
+19.39pp+16.06pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0031.9663.9195.87127.83Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Marathon Nextgen Q2: Consol PAT Falls 32% YoY to ₹45 Cr Despite 10% Revenue Growth

real estate · margin compression · merger nclt

ResultsQ2 FY2721 Oct 20263 minReal Estate

Marathon Nextgen Realty Q2: Watch for Project Momentum & Merger Clarity

real estate · Mumbai · redevelopment

Result previewQ2 FY2718 Oct 20263 minReal Estate

Growth Without Profit — The Quarter Marathon Can't Spin

margin compression · Monte South · collections

Result verdictFollow-upQ1 FY2717 Aug 20266 minReal Estate
Latest
Board Meeting21 Oct, 8:50 pm

Marathon Nextgen Q2: Consol PAT Falls 32% YoY to ₹45 Cr Despite 10% Revenue Growth

Marathon Nextgen Realty's consolidated Q2 FY27 (quarter ended September 30, 2026) net profit fell 32.1% year-on-year to ₹45.19 Cr from ₹66.54 Cr, even as consolidated revenue from operations grew 10.4% YoY to ₹128.95 Cr from ₹116.85 Cr — a profit decline despite topline growth is the primary signal this quarter. Sequentially both lines were down from Q1 FY27 (revenue -34.7%, PAT -13.8%), but that comparison is a base-effect artifact: Q1's ₹197.50 Cr revenue was itself a multi-quarter high, not a run-rate. No external sell-side consensus exists for this stock (web search found price-target commentary but no Q2 estimate); against our own pre-result preview range (revenue ₹180-220 Cr, PAT ₹40-55 Cr, EBITDA margin 28-32%), the quarter missed on revenue, landed within range on PAT, and beat on margin — netting out to a miss given revenue is the larger shortfall. The YoY squeeze sits mainly on net margin: NPM compressed to 31.2% of total income from 42.9% a year ago (-11.7pp), while operating margin held comparatively steady at 34.97% versus 35.96% YoY. That gap implies the erosion is less about the core property-development cost mix and more about items below operating profit and a tough prior-year comparison base (Q2 FY26's 42.9% NPM was unusually high). Standalone entity profitability (₹47.79 Cr PAT, EPS ₹7.09) was actually higher than the consolidated figure and nearly flat YoY (-1.1% revenue), underscoring that consolidated YoY growth comes from subsidiaries and the joint-venture share (₹3.53 Cr), not the parent — an 11-point-plus divergence between standalone and consolidated revenue growth worth flagging since readers will see both numbers. Management gave no explicit FY27 revenue or PAT target on the last call, so there is no formal topline/bottom-line guidance to grade; the firmer commitment was to deploy ₹200 Cr of capital at a 30-35% EBITDA hurdle and launch new redevelopment projects (Versova/Sewri, ~₹900 Cr GDV) selectively. This quarter's ~35% OPM clears that margin hurdle, but the Board's own outcome letter states the agenda item for new investments in Projects/SPVs 'was deferred' — the capital-deployment decision flagged for this quarter did not happen, a miss on that specific timeline. Separately, merger integration advanced: the Company Scheme Petition (second motion) was filed with the NCLT on September 24, 2026, following the September 8 shareholder approval of the five-entity amalgamation. QIP proceeds of ₹899.99 Cr are now ~77% utilized (₹695.40 Cr), with the ₹203.79 Cr balance parked in mutual funds, debentures and bonds. No separate management press release was available in the record to check messaging against the numbers. Going into Q3, the deferred investment decision and the pending NCLT scheme hearing are the concrete items to track, alongside whether NPM recovers toward its historical 40%+ band or settles near this quarter's low-30s level.

21 Oct 2026, 08:50 pm

Corporate Events

Board MeetingMARATHON
2026
21Oct

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingMARATHON
2026
28Sep

Board Meeting

The 49th AGM of the Company is scheduled to be held on Septe…

BSE Filing ↗
DividendMARATHON
2026
18Sep

₹1 / share

BSE Filing ↗
Board MeetingMARATHON
2026
7Sep

Board Meeting

Notice of the NCLT convened meeting of the Equity Shareholde…

BSE Filing ↗
Board MeetingMARATHON
2026
7Aug

Board Meeting

To consider and approve of Unaudited Financial Results (Stan…

BSE Filing ↗
Board MeetingMARATHON
2026
27May

Board Meeting

To consider and approve Audited Financial Results (Standalon…

BSE Filing ↗
DividendMARATHON
2025
19Sep

₹1 / share

BSE Filing ↗
Board MeetingMARATHON
2025
31Mar

Board Meeting

consider the prospects of a potential consolidation of busin…

BSE Filing ↗
DividendMARATHON
2024
18Sep

₹71 / share

BSE Filing ↗
Board MeetingMARATHON
2024
28May

Board Meeting

Consider and approve Audited Financial Results (Standalone a…

BSE Filing ↗
Board MeetingMARATHON
2023
1Nov

Board Meeting

Consider and approve Unaudited Financial Results (Standalone…

BSE Filing ↗